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The liver kinase B1 (LKB1)-AMP activated protein kinase (AMPK)
pathway regulates cellular metabolism, polarity, and growth. Although pre-
vious studies have documented the maladaptive consequences of LKB1
deletion in the progressive development of atrial fibrillation (AF) and car-
diac hypertrophy, its role in chamber-specific pathophysiology remains
largely unresolved. Therefore we systematically explored LKB1’s differen-
tial effects on structural and ion channel remodeling in mice with LKB1
deletion in cardiomyocytes. Atrial but not ventricular Nav1.5 and Cx40
expression levels were markedly downregulated in 1d neonates, giving
rise to a 2-fold prolongation of the P wave on surface ECG. Detailed ex
vivo optical action potential (AP) mapping studies revealed presence of
marked inter-atrial conduction abnormalities, loss of bi-atrial electrical
coupling, and prolonged AP durations in the atria of mice with LKB1 dele-
tion. In contrast, ventricular changes developed with a much slower time-
course that was consistent with previous studies. AMPK a2 inactivated
hearts demonstrated modest overlap in ion channel expression, but retained
normal ECG characteristics, cardiac structure and function compared to their
LKB1 deleted counterparts. LKB1 deletion triggers a primary atrial electro-
physiological remodeling program that precedes structural abnormalities and
likely underlies the development of AF. LKB1 may be a novel target for the
prevention of AF.
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Type-4 cardiorenal syndrome patients develop heart failure as result of kidney
failure. While the mechanism of cardiac dysfunction is unknown, elevated
levels of circulating endogenous Na/K ATPase inhibitors (NKAi) are detected
in patients and animals with kidney failure. We investigated the pathophysio-
logical consequences of NKAi elevation in rat myocytes and hearts of animals
with chronic kidney disease (CKD).
Methods: Intracellular Na concentration ([Nai]) was measured using fluores-
cent ratio-imaging microscopy and ERK1/2 phosphorylation by western blot-
ting, in adult rat ventricular myocytes. Cardiac Na/K ATPase (NKA) activity
was measured using biochemical NKA assays. CKD was induced in rats via
5/6 partial-nephrectomy (PN) or in mice via folic-acid administration (FA).
Creatinine serum levels were increased in both models, with kidney dysfunc-
tion (and cardiac hypertrophy) being more severe in PN model.
Results: Treatment of field-stimulated rat cardiac myocytes with bufalin
(10nM) or ouabain (100nM) significantly increased [Nai] by 1.250.3 and
1.950.2mM, respectively, whereas, concentrations of marinobuganenin below
1mM did not. Furthermore, NKAi activated hypertrophic signaling cascades
(assessed by ERK1/2 phosphorylation) with a potency order of bufalin
(EC50=70nM)>ouabain (EC50=93nM)> marinobuganenin (EC50=6.4mM).
Despite small but significant increases in NKA alpha-1/2 expression, NKA ac-
tivity in hearts of animals with kidney dysfunction was reduced by 45519% in
PN (6 weeks post-PN) and 3459% in FA animals (12 weeks post FA-
injection). NKA inhibition was reversed by incubation with a polyclonal
anti-Digoxin antibody (binds most structurally-related NKAi), confirming
involvement of NKAi.
Conclusions: Pathophysiologically-relevant concentrations of bufalin and
ouabain, but not marinobufagenin, raise [Nai] and activate hypertrophic
signaling pathways in the heart, thus contributing to Na and diastolic Ca over-
load and hypertrophy, during CKD.1550-Pos Board B280
b-Adrenergic Regulation of Cyclic AMP and Ca Current at the T-Tubules
and Surface Membrane in Rat Cardiomyocytes
Rodolphe Fischmeister, Cristina E. Molina, Youn Kyoung Son.
INSERM U769, Chaˆtenay-Malabry, France.
b-Adrenoceptor (b-AR) signalling is severely impaired in heart failure (HF),
and this is accompanied by a loss and disorganization of t-tubules. However,
how the latter affects the former is unknown. Here, we examined how acute de-
tubulation affects the b-AR response of L-type Ca2þ channel (LTCC) current
(ICa,L) and membrane cAMP ([cAMP]m) in adult rat ventricular myocytes
(ARVMs) and the contribution of phosphodiesterases PDE3 and PDE4 in this
process. ARVMs were infected with an adenovirus encoding a mutant of the
olfactory cyclic nucleotide-gated (CNG) channels a subunit to follow [cAMP]m
dynamics by recording the associated cationic current. [cAMP]mwas also moni-
tored by fluorescent imaging using a FRET-based sensor encoding a plasma-
membrane targeted cAMP probe (Epac2-camps). Osmotic shock treatment
with 1.5M formamide during 15 min induced a loss of t-tubule network as veri-
fied by confocal imaging with di-8-ANEPPS staining. Detubulation of ARVMs
reduced membrane capacitance by 40% and basal ICa,L density ~3-fold. Short
(15s) applications of isoprenaline (Iso 100nM) increased ICa,L ~2.5-fold simi-
larly in both conditions but had a 30% smaller effect on [cAMP]m in detubulated
ARVMs. After Iso washout, ICa,L and [cAMP]m returned to basal with a ~1.5-
fold faster kinetic in detubulated ARVMs than in control, suggesting a faster
cAMP degradation by PDEs. The contribution of PDE3 and PDE4 was thus
tested using the inhibitors cilostamide (1mM) and Ro20-1724 (10mM), respec-
tively. Both inhibitors had a more pronounced effect on Iso response of ICa,L
and [cAMP]m in detubulated ARVMs. Thus, detubulation per se has a profound
effect on the b-AR signalling cascade whichmay contribute to its impairment in
HF. This is partly due to a change in the respective contributions of PDE3 and
PDE4 to the hydrolysis of cAMP near the membrane and LTCCs.
1551-Pos Board B281
Wnt Signaling Promotes Pacemaker Myocyte Specification of Differenti-
ating Cardiac Progenitor Cells
Wenbin Liang, Elizabeth H. Kim, Jordan Mak, Eduardo Marba´n, Hee Cheol
Cho.
Cardiology, Cedars-Sinai Heart Institute, Los Angeles, CA, USA.
Embryonic stem cells (ESCs) can give rise to cardiomyocytes, but mechanisms
of cardiac subtype specification to either pacemaker cells or chamber (atrial/
ventricular) cardiomyocytes remain little understood. Canonical Wnt signaling
plays a key role for ESC maintenance and becomes inactivated during differ-
entiation. We hypothesized that control of Wnt signaling by Dkk1, an endog-
enous secreted protein inhibitor of canonical Wnt signaling, may impact
cardiac subtype specification during ESC differentiation. Mouse ESCs were
treated with activin-A and BMP-4 for 40 hours to initiate cardiac differentia-
tion. Flk-1þ/PdgfR-aþ cardiac progenitors were FACS-purified and seeded
as monolayers (day-4). The monolayers were either treated with a saturating
level of exogenous Dkk1 (‘‘exo-Dkk1", 150 ng/ml), or cultured in the endoge-
nous level of Dkk1 (‘‘endo-Dkk1", 3.2 ng/ml). At day-8, ~50% of cells were
positive for cTnT, a pan-cardiac myocyte marker, in both groups. Endo-
Dkk1 group exhibited significantly higher levels of cardiac pacemaker cell
markers (Tbx18 and Shox2), but lower levels of chamber lineage markers
(Nkx2.5, Isl1, Scn5a and Cacna1c, p<0.01). At day-10, endo-Dkk1 group
began to beat faster compared to exo-Dkk1 monolayers, and the superior auto-
maticity became more accentuated upon further differentiation (161.5511.5
vs. 48.052.9 bpm, endo- vs. exo-Dkk1, week-3). Endo-Dkk1 monolayers
yielded more cells with spontaneous intracellular calcium oscillations
compared to exo-Dkk1. Single, spontaneously-beating cells isolated from the
endo-Dkk1 monolayers were frequently spindle-shaped, exhibited robust
HCN4 proteins and I(f) currents, and fired rhythmic action potentials
(288551 bpm, n ¼ 5). Analogous results were attained with two other endog-
enous Wnt antagonists, Sfrp1 and Sfrp5. Our data demonstrate that the endog-
enous Wnt pathway of differentiating ESCs promotes specification of cardiac
pacemaker cell, rather than chamber cardiomyocytes. Our findings provide a
control point to enrich either pacemaker cell or chamber myocyte population.
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Dietary flavonoids are thought to contribute to the prevention of cardiovascular
disease. Recently we showed that 2,3-dehydrosilybin (DHSB) attenuated
